Skip to main content

Peer Review reports

From: Efficacy and safety of treat-and-extend intravitreal brolucizumab in naive and switched patients with macular neovascularization: one-year follow-up study

Original Submission
10 Mar 2024 Submitted Original manuscript
30 Jul 2024 Reviewed Reviewer Report - Pia Allegri
5 Aug 2024 Reviewed Reviewer Report
12 Aug 2024 Reviewed Reviewer Report
10 Sep 2024 Author responded Author comments - Carlo Alessandro Lavia
30 Sep 2024 Reviewed Reviewer Report
Resubmission - Version 2
10 Sep 2024 Submitted Manuscript version 2
Publishing
30 Sep 2024 Editorially accepted
4 Oct 2024 Article published 10.1186/s12886-024-03706-0

You can find further information about peer review here.

Back to article page